PIROUETTE PHARMA INC. — Form D
PIROUETTE PHARMA INC. of PORTSMOUTH, NH, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-02. The offering totals $10.6M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-09-02
- Form: D
- Accession: 0001870611-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.6M
- Amount sold: $7.0M
- Remaining: $3.6M
- Investors: 29
- Date of first sale: 2021-08-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-412235
Issuer
- Name: PIROUETTE PHARMA INC.
- CIK: 0001870611
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 200 INTERNATIONAL DRIVE, PORTSMOUTH, NH, 03801
- Phone: (617) 545-4768
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Arunas Chesonis | Director | Boston, MA |
| Arunas Chesonis | Executive Officer | Boston, MA |
| JOSEPH NEMMERS | Executive Officer | PORTSMOUTH, NH |
| Arunas Chesonis | Promoter | Boston, MA |
| JOSEPH NEMMERS | Promoter | PORTSMOUTH, NH |
| Parinaz Motamedy | Director | Cambridge, MA |
| ELIJAH KAPAS | Director | PORTSMOUTH, NH |
| ELIJAH KAPAS | Executive Officer | PORTSMOUTH, NH |
| ELIJAH KAPAS | Promoter | PORTSMOUTH, NH |
| MATTHEW KANE | Director | PORTSMOUTH, NH |
| MATTHEW KANE | Executive Officer | PORTSMOUTH, NH |
| MATTHEW KANE | Promoter | PORTSMOUTH, NH |
| CONOR CULLINANE | Director | PORTSMOUTH, NH |
| CONOR CULLINANE | Executive Officer | PORTSMOUTH, NH |
| CONOR CULLINANE | Promoter | PORTSMOUTH, NH |
| JOSEPH NEMMERS | Director | PORTSMOUTH, NH |
Other filings by this issuer (4)
More